Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Neurobiol Dis ; 77: 173-90, 2015 May.
Article in English | MEDLINE | ID: mdl-25753471

ABSTRACT

Down Syndrome (DS), trisomy 21, is characterized by synaptic abnormalities and cognitive deficits throughout the lifespan and with development of Alzheimer's disease (AD) neuropathology and progressive cognitive decline in adults. Synaptic abnormalities are also present in the Ts65Dn mouse model of DS, but which synapses are affected and the mechanisms underlying synaptic dysfunction are unknown. Here we show marked increases in the levels and activation status of TrkB and associated signaling proteins in cortical synapses in Ts65Dn mice. Proteomic analysis at the single synapse level of resolution using array tomography (AT) uncovered increased colocalization of activated TrkB with signaling endosome related proteins, and demonstrated increased TrkB signaling. The extent of increases in TrkB signaling differed in each of the cortical layers examined and with respect to the type of synapse, with the most marked increases seen in inhibitory synapses. These findings are evidence of markedly abnormal TrkB-mediated signaling in synapses. They raise the possibility that dysregulated TrkB signaling contributes to synaptic dysfunction and cognitive deficits in DS.


Subject(s)
Cerebral Cortex/metabolism , Cerebral Cortex/pathology , Down Syndrome/pathology , Receptor, trkB/metabolism , Signal Transduction/physiology , Synaptosomes/metabolism , Animals , Brain-Derived Neurotrophic Factor/metabolism , Brain-Derived Neurotrophic Factor/pharmacology , Disease Models, Animal , Down Syndrome/genetics , Down Syndrome/metabolism , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Humans , Male , Mice , Mice, Transgenic , RNA, Messenger/metabolism , Signal Transduction/genetics , Synaptosomes/drug effects
2.
JAMA ; 310(6): 591-608, 2013 Aug 14.
Article in English | MEDLINE | ID: mdl-23842577

ABSTRACT

IMPORTANCE: Understanding the major health problems in the United States and how they are changing over time is critical for informing national health policy. OBJECTIVES: To measure the burden of diseases, injuries, and leading risk factors in the United States from 1990 to 2010 and to compare these measurements with those of the 34 countries in the Organisation for Economic Co-operation and Development (OECD) countries. DESIGN: We used the systematic analysis of descriptive epidemiology of 291 diseases and injuries, 1160 sequelae of these diseases and injuries, and 67 risk factors or clusters of risk factors from 1990 to 2010 for 187 countries developed for the Global Burden of Disease 2010 Study to describe the health status of the United States and to compare US health outcomes with those of 34 OECD countries. Years of life lost due to premature mortality (YLLs) were computed by multiplying the number of deaths at each age by a reference life expectancy at that age. Years lived with disability (YLDs) were calculated by multiplying prevalence (based on systematic reviews) by the disability weight (based on population-based surveys) for each sequela; disability in this study refers to any short- or long-term loss of health. Disability-adjusted life-years (DALYs) were estimated as the sum of YLDs and YLLs. Deaths and DALYs related to risk factors were based on systematic reviews and meta-analyses of exposure data and relative risks for risk-outcome pairs. Healthy life expectancy (HALE) was used to summarize overall population health, accounting for both length of life and levels of ill health experienced at different ages. RESULTS: US life expectancy for both sexes combined increased from 75.2 years in 1990 to 78.2 years in 2010; during the same period, HALE increased from 65.8 years to 68.1 years. The diseases and injuries with the largest number of YLLs in 2010 were ischemic heart disease, lung cancer, stroke, chronic obstructive pulmonary disease, and road injury. Age-standardized YLL rates increased for Alzheimer disease, drug use disorders, chronic kidney disease, kidney cancer, and falls. The diseases with the largest number of YLDs in 2010 were low back pain, major depressive disorder, other musculoskeletal disorders, neck pain, and anxiety disorders. As the US population has aged, YLDs have comprised a larger share of DALYs than have YLLs. The leading risk factors related to DALYs were dietary risks, tobacco smoking, high body mass index, high blood pressure, high fasting plasma glucose, physical inactivity, and alcohol use. Among 34 OECD countries between 1990 and 2010, the US rank for the age-standardized death rate changed from 18th to 27th, for the age-standardized YLL rate from 23rd to 28th, for the age-standardized YLD rate from 5th to 6th, for life expectancy at birth from 20th to 27th, and for HALE from 14th to 26th. CONCLUSIONS AND RELEVANCE: From 1990 to 2010, the United States made substantial progress in improving health. Life expectancy at birth and HALE increased, all-cause death rates at all ages decreased, and age-specific rates of years lived with disability remained stable. However, morbidity and chronic disability now account for nearly half of the US health burden, and improvements in population health in the United States have not kept pace with advances in population health in other wealthy nations.


Subject(s)
Chronic Disease/mortality , Cost of Illness , Health Status , Life Expectancy , Wounds and Injuries/mortality , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Developed Countries/statistics & numerical data , Disabled Persons/statistics & numerical data , Female , Global Health , Humans , Infant , Male , Middle Aged , Morbidity , Mortality, Premature , Risk Factors , United States/epidemiology
3.
Pak J Biol Sci ; 11(13): 1768-70, 2008 Jul 01.
Article in English | MEDLINE | ID: mdl-18819637

ABSTRACT

The effect of one entomopathogenic virus (PxGV) was studied on cabbage moth Plutella xylostella with hope to find management strategies of this insect, based on biological control. Bioassay showed that, this virus has high virulence and can be considered as the important agents on the control of this insect. The LC50 value of PxGV for second instar larvae of cabbage moth was calculated 448.58 g mm(-2). The LT50 values for the same larvae with 749.89 and 1883.65 g mm(-2) doses of PxGV were 6.04 and 6.85 days, respectively.


Subject(s)
Animal Diseases/virology , Brassica , Lepidoptera/virology , Animals , Laboratories , Larva/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...